EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of 131I SPECT/CT on Therapeutic Decision-Making in Differentiated Thyroid Carcinoma: A Single-Center Retrospective Study

Maria L S Pontes, Alinne F A Verçosa, Mariana C L Lima, Ligia V M Assumpção, Denise E Zantut-Wittmann, Celso Dario Ramos

Academic Radiology · 2026-08

DOI: 10.1016/j.acra.2026.08.020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academic Radiology, 2026-08. Verfasst von Maria L S Pontes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology of the Department of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil (M.L…. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, State of Sao Paulo Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

RATIONALE AND OBJECTIVES: Differentiated thyroid carcinoma (DTC) has a favorable prognosis when properly managed. Whole-body scanning (WBS) is the standard functional imaging method for post-surgical staging; however, its limited spatial resolution may lead to misclassification of iodine-131 (131I) uptake sites. Single-photon emission computed tomography/computed tomography (SPECT/CT) improves anatomical localization and diagnostic accuracy. We aimed to evaluate the incremental clinical value of SPECT/CT over WBS in determining the 131I therapeutic dose in patients with DTC. MATERIALS AND METHODS: This retrospective study included 199 patients with DTC treated at a tertiary academic center between 2011 and 2017. WBS-based management decisions were compared with those incorporating SPECT/CT findings. Agreement was assessed using the intraclass correlation coefficient (ICC) and Kappa. RESULTS: SPECT/CT changed therapeutic management in 20.6% of patients (n = 41). The administered 131I activity was reduced in 27 of these patients (65.9%), preventing overtreatment, and increased in 14 (34.1%), preventing undertreatment. By staging, 26 patients (63.4%) were downstaged, and 15 (36.6%) were upstaged; in one upstaged patient, a surgically resected bone metastasis led to a dose reduction rather than an increase. Overall dose agreement was good (ICC = 0.833; 95% confidence interval [CI]: 0.785-0.871). Concordance was very high for T staging (κ = 0.977), M staging (κ = 0.931), and risk category (κ = 0.971), but only moderate for lymph node evaluation (κ = 0.589; 95% CI: 0.478-0.700). Predictors of management change included: cervical uptake (P < 0.001), lymph node involvement on WBS (P = 0.004), proposed WBS dose (P = 0.013), cumulative prior 131I dose (P = 0.027), and undetectable antithyroglobulin antibodies (P = 0.032). CONCLUSION: SPECT/CT after WBS has a significant clinical impact in DTC, enabling more personalized therapy and reducing both undertreatment and overtreatment in approximately one-fifth of patients, with its greatest contribution in lymph node characterization.

Schlagwörter

Stichwörter der Autor:innen

Differentiated thyroid carcinomaIodine-131Radioiodine therapySingle-photon emission computed tomographyThyroid neoplasms

Autor:innen und Institutionen

  • Division of Endocrinology of the Department of Internal Medicine, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil (M.L.S.P., L.V.M.A., D.E.Z.-W.).
  • Division of Nuclear Medicine, Department of Radiology and Oncology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil (A.F.A.V., M.C.L.L., C.D.R.).
  • Division of Nuclear Medicine, Department of Radiology and Oncology, School of Medical Sciences, University of Campinas (UNICAMP), Campinas, Brazil (A.F.A.V., M.C.L.L., C.D.R.). Electronic address: cdramos@unicamp.br.

Förderung

  • National Council for Scientific and Technological Development
  • State of Sao Paulo Research Foundation

Zitieren

APA

Pontes, M. L. S., Verçosa, A. F. A., Lima, M. C. L., Assumpção, L. V. M., Zantut-Wittmann, D. E., & Ramos, C. D. (2026). Impact of 131I SPECT/CT on Therapeutic Decision-Making in Differentiated Thyroid Carcinoma: A Single-Center Retrospective Study. Academic Radiology. https://doi.org/10.1016/j.acra.2026.08.020

Vancouver

Pontes MLS, Verçosa AFA, Lima MCL, Assumpção LVM, Zantut-Wittmann DE, Ramos CD. Impact of 131I SPECT/CT on Therapeutic Decision-Making in Differentiated Thyroid Carcinoma: A Single-Center Retrospective Study. Academic Radiology. 2026. doi:10.1016/j.acra.2026.08.020

BibTeX
@article{Pontes2026,
  author = {Pontes, Maria L S and Verçosa, Alinne F A and Lima, Mariana C L and Assumpção, Ligia V M and Zantut-Wittmann, Denise E and Ramos, Celso Dario},
  title = {Impact of 131I SPECT/CT on Therapeutic Decision-Making in Differentiated Thyroid Carcinoma: A Single-Center Retrospective Study},
  journal = {Academic Radiology},
  year = {2026},
  doi = {10.1016/j.acra.2026.08.020}
}
Kostenlos starten →